CPHI Milan 2026

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Decision Integrity: The Layer ALCOA+ Was Never Built to Cover

    When a model helps make a GxP call the data underneath it can be spotless and the decision still indefensible Here is where the gap opens and the controls that close it For years the discipline that has kept regulated records trustworthy is data integrity We learned ALCOA then ALCOA and built whole quality systems around the idea that a record has to be attributable legible contemporaneous origin...

    Enhancing Drug Quality and Efficiency with Smart Manufacturing

    Smart manufacturing development leads the pharmaceutical industry toward a substantial industrial shift Current regulatory oversight has created production cost challenges that manufacturers face while managing drug safety requirements for highquality medicine production What are the methods by which technology can change the production methods of drugs What position does automation and artificial...

    Digital Bioprocessing: AI and Automation in Biologics Manufacturing

    For most of the modern biologics era a mammalian cell culture batch was managed the way a ship is navigated in fog a fixed course periodic position checks and very little ability to correct midvoyage Operators set a feed strategy pulled offline samples once or twice a day and waited for the analytics to say whether the batch had drifted By the time a titre shortfall or a glycosylation shift appear...

    The Role of European Pharma in Global Healthcare Advancements

    Europe is one of the largest players in the international market for health care due to research development and innovation and competitive pharmaceutical industries Some of these European pharma medical research organizations and health care systems have continually provided valuable solutions to the welfare of people globally It is an increasingly important role for them to play given that they...

    The Competitive Generic Therapy (CGT)

    Generic medications are critical in the healthcare sector due to their affordability and accessibility to the public while maintaining comparable quality efficacy and safety to that of branded products Generic medications research and development followed by commercialisation also fosters competition and innovation within the pharmaceutical

    Fostering Pharma Collaboration: Challenges & Opportunities

    In the everevolving world of pharmaceuticals fostering collaboration is essential for driving innovation and meeting the diverse needs of patients However this seemingly simple goal is often hindered by numerous challenges

TOP ARTICLES

  • 4

    The Competitive Generic Therapy (CGT)

    Raghunandhan Painoori

    Dr. Naveen Chella

    The Competitive Generic Therapy (CGT) Act, introduced by the US FDA in 2017 under the Generic Drug User Fee Act (GDUFA), aims to lower drug costs by promoting generics where competition is limited. It...

press releases Read more...

Dsm-firmenich launches Biond™ to advance biologics innovation

Dsmfirmenich announces the launch of Biond at CPHI Milan a dedicated portfolio of pharmaceuticalgrade vitamins for biopharmaceutical applications

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate

Arvinas Inc Nasdaq ARVN a clinicalstage biotechnology company creating a new class of drugs based on targeted protein degradation today announced that the first participant has been dosed in its

Mirum Pharmaceuticals maakte bekend dat het primaire eindpunt is bereikt in de Fase 3 AZURE-1 studie van brelovitug bij chronische hepatitis delta-virus

Mirum Pharmaceuticals Inc Nasdaq MIRM een toonaangevend bedrijf gespecialiseerd in zeldzame aandoeningen maakte vandaag bekend dat het primaire eindpunt is voldaan in het Fase gedeelte van de AZURE

Vetter Expands Global Manufacturing Network to Support Future Customer Needs

Vetter a leading Contract Development and Manufacturing Organization CDMO continues to expand its commercial fillandfinish network to further strengthen its global manufacturing operations and support the evolving needs of pharma and biotech customers The companys longterm investment

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

05 - 06

Oct 2026

ISPSAI France 2026

Paris, France

05 - 08

Oct 2026

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

12 - 13

Oct 2026

2nd International Conference on Drug Discovery

Village Hotel Changi, Singapor...

LATEST NEWS Read more...

Novonesis Expands West Allis Facility to Strengthen North American Dairy Production

Novonesis has completed a major expansion of its production facility in West Allis Wisconsin increasing its North American capacity for dairy cultures The investment has raised fermentation capacity

4basebio and TriLink BioTechnologies Partner to Support Phase I Cell Therapy Programme

basebio has announced a partnership with TriLink BioTechnologies to support a Phase I cell therapy programme being developed by a multinational pharmaceutical company

Astoriom Acquires Additional UK Storage Business to Expand Capacity and Services

Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited the UK operations of life sciences stability storage provider Sampled based in Glasgow The acquisition expands

Variant Bio Expands Target Discovery Collaboration with Boehringer Ingelheim into Cardiovascular Disease

Variant Bio has expanded its multiyear research collaboration and licensing agreement with Boehringer Ingelheim to identify and validate new drug targets for cardiovascular disease

SK pharmteco and GEMMABio strengthen rare disease manufacturing collaboration

SK pharmteco has expanded its collaboration with clinicalstage gene therapy company GEMMABio to support the manufacture of materials for the companys Phase CHARISMA clinical trial for spinal muscular

Envisagenics and Boehringer Ingelheim enter multi-target collaboration for cancer therapi

Envisagenics has entered a multiyear research collaboration and option agreement with Boehringer Ingelheim to investigate tumourspecific targets for potential precision therapies for solid tumours